Clinical Trial Update: Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for tranexamic acid in hip fractures (intertrochanteric and subtrochanteric femur fractures) to reduce surgical blood lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Intertrochanteric Fracture of Femur
• Subtrochanteric Fracture of Femur

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Good Samaritan Regional Medical Center, Oregon | Conditions: Hip Fractures, Surgical Blood Loss | Phase 4 | Status: UNKNOWN